- Home
- THQ vs NAGE Comparison
THQ vs NAGE Comparison
Compare THQ & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THQ
- NAGE
- Stock Information
- Founded
- THQ 2014
- NAGE 1999
- Country
- THQ United States
- NAGE United States
- Employees
- THQ N/A
- NAGE N/A
- Industry
- THQ Finance Companies
- NAGE Medicinal Chemicals and Botanical Products
- Sector
- THQ Finance
- NAGE Health Care
- Exchange
- THQ Nasdaq
- NAGE Nasdaq
- Market Cap
- THQ 714.6M
- NAGE 766.4M
- IPO Year
- THQ N/A
- NAGE N/A
- Fundamental
- Price
- THQ $18.00
- NAGE $7.24
- Analyst Decision
- THQ
- NAGE Strong Buy
- Analyst Count
- THQ 0
- NAGE 3
- Target Price
- THQ N/A
- NAGE $17.00
- AVG Volume (30 Days)
- THQ 158.9K
- NAGE 1.2M
- Earning Date
- THQ 01-01-0001
- NAGE 11-04-2025
- Dividend Yield
- THQ 7.53%
- NAGE N/A
- EPS Growth
- THQ N/A
- NAGE N/A
- EPS
- THQ N/A
- NAGE 0.22
- Revenue
- THQ N/A
- NAGE $116,303,000.00
- Revenue This Year
- THQ N/A
- NAGE $29.51
- Revenue Next Year
- THQ N/A
- NAGE $20.55
- P/E Ratio
- THQ N/A
- NAGE $33.78
- Revenue Growth
- THQ N/A
- NAGE 35.90
- 52 Week Low
- THQ $15.29
- NAGE $3.49
- 52 Week High
- THQ $20.38
- NAGE $14.69
- Technical
- Relative Strength Index (RSI)
- THQ 55.78
- NAGE 36.00
- Support Level
- THQ $18.11
- NAGE $7.23
- Resistance Level
- THQ $18.31
- NAGE $7.70
- Average True Range (ATR)
- THQ 0.23
- NAGE 0.29
- MACD
- THQ -0.02
- NAGE 0.07
- Stochastic Oscillator
- THQ 55.71
- NAGE 11.36
About THQ abrdn Healthcare Opportunities Fund Shares of Beneficial Interest
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. The fund's investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies.
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.